Cognitive-Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes (CAMINANDO) in Survivors of Severe Acute Respiratory Failure
用于改善严重急性呼吸衰竭幸存者的神经和身体残疾结果 (CAMINANDO) 的认知运动干扰评估
基本信息
- 批准号:9900060
- 负责人:
- 金额:$ 17.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAcute respiratory failureAddressAdult Respiratory Distress SyndromeAncillary StudyAreaAwardBiological MarkersClinicalClinical ManagementClinical TrialsClinical Trials NetworkCognitionCognitiveComplexCritical CareCritical IllnessDementiaDevelopment PlansEarly treatmentElderlyEnrollmentEquationEvaluationFeedbackFundingGeriatricsGoalsGrantHospitalsImpaired cognitionImpairmentInduction of neuromuscular blockadeInflammatoryInstitutionIntensive Care UnitsInterleukin-6InternationalK-Series Research Career ProgramsKnowledgeLongitudinal prospective studyLongterm Follow-upLungMeasuresMechanical ventilationMentorsMentorshipModelingMotorMultiple SclerosisNational Heart, Lung, and Blood InstituteNeurodegenerative DisordersNeurologicNeurologyOrgan failureOutcomePatientsPatternPerformancePhysical FunctionPhysical MedicinePlasmaPlayPreventionPrincipal InvestigatorProcessRandomizedRandomized Clinical TrialsRecommendationRecoveryRehabilitation therapyReportingResearchResearch PersonnelResearch Project GrantsResearch ProposalsResearch TrainingRiskRisk AssessmentSiteSpeedStrokeStructureSurvivorsSyndromeTestingTimeTrainingTraumatic Brain InjuryUnited States National Institutes of HealthWorkadverse outcomebasecareercareer developmentclinical epidemiologycognitive functioncognitive performancecognitive taskcostdesigndisabilityeffectiveness testingexperienceimprovedimproved mobilityimproved outcomemeetingsmemberminority investigatormortalitymotor impairmentmultidisciplinaryneuromuscular systemnovelnovel strategiespatient populationphysically handicappedpreventskillstreatment as usualworking group
项目摘要
Project Summary/Abstract
Severe acute respiratory failure is the most common organ failure in the intensive care unit, the most severe
form of which is acute respiratory failure syndrome. Understanding and preventing the long-term physical and
cognitive impairments that is the legacy of surviving acute respiratory failure (ARF) is the career goal of this
junior minority investigator with previous clinical training in Pulmonary, Critical Care and research training in
Clinical Epidemiology. Although previous research in ARF has examined mobility outcomes independently
from the cognitive outcomes, emerging evidence suggests that mobility and cognitive outcomes are
intertwined. Cognitive Motor Interference (CMI) is an emerging risk assessment and treatment approach for
improving disability outcomes in many patient populations. Dr. Hope describes a mentored research project
and specific career development plan which will enable him to become an expert in CMI assessments in
patients with acute respiratory failure. The research proposal aims to leverage the NHLBI funded Prevention
and Early Treatment of Acute Lung Injury (PETAL) network to define the scope, pattern and predictive validity
of assessing acute respiratory failure patients for CMI while in the hospital. The research proposal's second
aim is to conduct a single-center randomized clinical trial of hospital based CMI-based training in acute
respiratory failure patients. During the award period, Dr. Hope has developed a structured plan to build on his
previous training by attaining skills in four additional areas: 1) measuring cognitive motor interference in acutely
ill patients; 2) understanding and intervening on disability outcomes after critical illness; 3) the management of
clinical trials and 4) structured equation modeling. As part of this career development award, Dr. Hope will be a
co-Principal Investigator for PETAL network studies at his institution and will serve as site Principal Investigator
for an NHLBI funded ancillary study called PRIMROSE. As a member of the PETAL Network Long-Term
Outcomes Working Group Committee, he will be involved, along with his mentors and collaborators, with
developing recommendations for measuring long-term outcomes in the PETAL network studies. Dr. Hope will
work closely with co-mentors in Neurology, Geriatrics and Critical Care with expertise in cognitive and mobility
outcomes; He will also work with advisors and collaborators in Rehabilitation Medicine with expertise in the
disability process in acutely ill patients. Through a mix of formal and informal coursework, practical experience,
local and international meetings along with directed feedback from this multi-disciplinary team of mentors and
advisors, Dr. Hope will be prepared to become an independent investigator by the end of this award period.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aluko A. Hope其他文献
Aluko A. Hope的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aluko A. Hope', 18)}}的其他基金
Cognitive-Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes (CAMINANDO) in Survivors of Severe Acute Respiratory Failure
用于改善严重急性呼吸衰竭幸存者的神经和身体残疾结果 (CAMINANDO) 的认知运动干扰评估
- 批准号:
10117281 - 财政年份:2018
- 资助金额:
$ 17.66万 - 项目类别:
Cognitive Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes in Survivors of Severe Acute Respiratory Failure (CAMINANDO) Phase II
用于改善严重急性呼吸衰竭幸存者的神经系统和身体残疾结果的认知运动干扰评估 (CAMINANDO) 第二阶段
- 批准号:
10621635 - 财政年份:2018
- 资助金额:
$ 17.66万 - 项目类别:
Frailty Assessment in the Intensive Care Unit and Short Term Outcomes in Older Patients (FRAIL-STOOP)
重症监护病房的衰弱评估和老年患者的短期结果 (FRAIL-STOOP)
- 批准号:
9125710 - 财政年份:2015
- 资助金额:
$ 17.66万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Fellowship